Protagenic Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Protagenic Therapeutics (PTIXW) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Protagenic Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Protagenic Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Protagenic Therapeutics by UBS Group
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $1 | 100 | 0.01 |
2022-09-30 | $0 | 108 | 0.00 |
2022-06-30 | $0 | 108 | 0.00 |
2022-03-31 | $0 | 108 | 0.00 |
2021-09-30 | $0 | 600 | 0.00 |
Top funds holding Protagenic Therapeutics
View all funds holding Protagenic Therapeutics